Amphastar Pharmaceuticals与南京医药签署供应协议,合作方为南京莱拓生物科技

美股速递
Mar 07

根据美国证券交易委员会(SEC)最新披露的文件,Amphastar Pharmaceuticals(AMPH)旗下南京医药于3月3日与南京莱拓生物科技有限公司正式达成供应合作协议。该协议的签署标志着双方在医药产品供应链领域建立起战略性合作关系。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10